| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of Clinical Laboratory Medicine (A.H., T.I.) and Endocrinology and Metabolism (K.Ka.), Dokkyo University School of Medicine, Mibu, Tochigi, 321-0293, Japan; Kuma Hospital (S.F., H.O., T.U., C.T., K.Ku., A.M.), Kobe, Hyogo, 650-0011, Japan; Department of Pediatrics (S.N., K.Ki.), Kumamoto University School of Medicine, Kumamoto, 860-8556, Japan; Department of Pediatrics (Y.N.), Hiroshima Red Cross Hospital, Hiroshima, 730-8691, Japan; Department of Physics (M.O.-I.), School of Science, and Department of Pediatrics (N.M.), School of Medicine, Kitasato University, Kanagawa, 228-8555, Japan; Research Institute of Environmental Medicine (Y.M.), Nagoya University, Nagoya, 464-8601, Japan; Ohyama Clinic (Y.O.), Sagamihara, Kanagawa, 228-8555, Japan; Department of Health Policy, National Center for Child Health and Development (S.H.), Setagaya, Tokyo, 157-8535, Japan; Department of Pediatrics, Graduate School of Medicine, University of Tokyo (S.K.), Bunkyo-ku, Tokyo, 113-8655, Japan; Takamatsu Endocrine Clinic (J.T.), Takatsuki, Osaka, 569-0804, Japan; and Department of Pediatrics (T.T.), Hokkaido University School of Medicine, Sapporo, 060-8638, Japan
Address all correspondence and requests for reprints to: Akira Hishinuma, M.D., Ph.D., Department of Clinical Laboratory Medicine, Dokkyo University School of Medicine, Mibu, Tochigi, 321-0293, Japan. E-mail: a-hishi{at}dokkyomed.ac.jp.
 |
Abstract |
|---|
 Top Abstract IntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Objectives: The purpose of this study was to investigate whether the three frequently found Tg mutations, namely C1058R, C1245R, and C1977S, were caused by a founder effect.
Results: We found 26 different mutations within the Tg gene in 52 patients from 41 families. Thirty-five patients were homozygous for the mutations, whereas the others were compound heterozygous. The occurrence of Tg mutation within the general Japanese population is one in 67,000. Patients with the C1245R mutation were found throughout Japan, whereas those with the C1058R mutation were confined to a small village on a southern island, and those with the C1977S mutation were restricted to a city. The eight patients with the C1058R mutation and the seven patients with the C1977S mutation all showed the same combinations of 18 single-nucleotide polymorphisms in the coding region of the Tg gene, which would appear in one in 810 million and one in 37 billion, respectively, control subjects.
Conclusions: The frequently found mutations, C1058R and C1977S, were caused by founder effects. This result suggests that Tg mutations may provide a genetic basis for the cause of familial euthyroid goiter.
|
Introduction |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
In this paper, we report on 52 Japanese patients with Tg mutations who were euthyroid to mildly hypothyroid. In addition to the previously reported Tg mutations C1058R, C1245R, C1977S, and G2356R (9, 10), we identified 22 novel mutations. Among them, three mutations, C1058R, C1245R, and C1977S, were frequently identified. In particular, two of the mutations, C1058R and C1977S, were found only in specific regions of Japan. Haplotype analysis confirmed that these two mutations were caused by a founder effect.
|
Subjects and Methods |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Seventy-six patients from 64 families were screened for mutations within the Tg gene. Twenty patients from 16 families showed high serum TSH at neonatal mass screening and goiters in early childhood. Fifty-six adult patients from 48 families were suspected of having Tg mutations because of clinical symptoms, laboratory tests, and histological findings. This study was approved by the ethical committee of Dokkyo University School of Medicine, and the patients or their parents expressed willingness to enroll in the study by signing informed consents.
Direct sequencing of Tg gene
Genomic DNA was isolated from the peripheral leukocytes using a QIAamp blood kit (QIAGEN, Hilden, Germany). All 48 exons and neighboring introns of the Tg gene were amplified using the Expand High-Fidelity PCR System (Roche, Mannheim, Germany) and directly sequenced by the Dye Terminator Cycle Sequencing Ready Reaction kit (Perkin-Elmer, Norwalk, CT) (10).
Haplotype analysis
To study allelic frequencies of single-nucleotide polymorphisms (SNPs) in the coding region of the Tg gene, the nucleotides at 2330 (exon 10), 2443 (exon 10), 2963 (exon 11), 3906 (exon 18), 4493 (exon 21), and 7920 (exon 46) in the Tg cDNA were sequenced in 10 healthy subjects (20 chromosomes) and that at 426 (exon 4) in 50 healthy subjects (100 chromosomes). The nucleotide frequency of the other 11 SNPs was reported previously (9). The likelihood of the haplotypes of the patients with the mutation C1058R, C1245R, and C1977S in a Japanese population was calculated by allelic frequencies of each SNP. First, the likelihood of occurrence of the two nucleotides at a particular SNP position was calculated by multiplying the likelihood of the two nucleotides. Then, the overall likelihood of the haplotype of each patient was calculated by multiplying the likelihood at all of the 18 SNP locations in individual patients.
|
Results |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
)Direct sequencing of genomic DNA showed mutations within the Tg gene in 52 patients from 41 families. We detected 26 different mutations: 18 missense mutations, four splice mutations, three nonsense mutations, and one single-nucleotide deletion. Thirty-five patients were homozygous for the mutations, whereas 17 patients were compound heterozygous. The mutations are located across the full length of the Tg gene.
|
and 2)
Among 16 patients born after 1979 when mass screening of hypothyroidism was initiated in Japan, 12 patients were positive at neonatal mass screening. Among the remaining four patients, only one patient born in 2001 with the mutation Q310P/C2135Y was confirmed negative at mass screening by her medical record. The other three patients who were born in 1980 or 1981 had no medical record. Seven patients positive at mass screening were maintained on thyroid hormone replacement therapy. Their serum TSH level was high and free T4 was low at mass screening (Table 2). Five patients positive at mass screening were either transiently treated with thyroid hormones or not treated at all. Their thyroid function tests showed subclinical hypothyroidism after 5 yr of age.
|
). The serum TSH levels were less than 10 mU/liter, except for one patient with the mutation C1245R/Q2638X who had a serum TSH of 51 mU/liter. Thyroid autoantibodies against Tg, thyroid peroxidase (TPO), and TSH receptor were negative in all the patients. Their serum Tg concentrations were low when compared with the size of goiter. Radioactive iodine uptake by the thyroid glands was high. In 12 patients who underwent an operation, abnormal Tg was suspected by typical histological findings of Tg mutations, which include empty-looking colloid in small follicles covered by tall (or cuboidal) follicular cells containing yellow-green granules (11). Prevalence of Tg mutations
The prevalence of Tg mutation was analyzed in the Kumamoto Prefecture of Japan. The total number of infants who underwent mass screening from 1990–1999 was 199,826. Among 155 infants whose serum TSH was more than 10 mU/liter, 111 infants were subsequently evaluated. Twenty-two infants suffered from abnormal thyroid development, six suffered from dyshormonogenesis, 25 suffered from mild persistent hypothyroidism without known causes, and 12 suffered from transient hypothyroidism. Because we identified three infants with Tg mutations, the incidence of Tg mutations is one in 67,000.
Founder effects
C1058R, C1245R, and C1977S mutations were frequently found in this study (Table 1). We found eight cases from five families homozygous for the C1058R mutation, 12 cases from 11 families homozygous for the C1245R mutation, and seven cases from five families homozygous for the C1977S mutation. To distinguish whether these mutations were derived from a common ancestral chromosome or an independently recurrent mutation, we analyzed 18 SNPs within the coding region of the Tg gene (Table 3). Eight patients homozygous for the C1058R mutation and seven patients homozygous for the C1977S mutation showed the same haplotypes, which based on statistical analysis would be expected to occur at a frequency of one in 810 million and one in 37 billion individuals, respectively. Therefore, our results suggest that the homozygous occurrence of these mutations is a result of a founder effect. However, the haplotypes of three patients homozygous for the C1245R mutation were different from the others, suggesting that some of the C1245R alleles were a result of independently recurrent mutations.
|
|
Discussion |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
In our series of patients, the symptoms were mild. Among 12 patients who were positive at neonatal mass screening, five were either transiently treated with thyroid hormones or not treated at all. In adult patients, the only clinical manifestation was longstanding goiter with euthyroidism or mild hypothyroidism. No patients developed mental retardation, even without treatment. Laboratory tests were compatible with Tg gene abnormalities, and the serum Tg concentrations of the patients were low compared with the size of goiter. No antibodies against Tg and TPO were detected. Radioactive iodine uptake was increased without organification defect under perchlorate discharge test. Histological studies pointed to abnormal protein trafficking from endoplasmic reticulum to Golgi, which is a frequent consequence of Tg gene mutations (14). We have shown that Tg mutations, C1245R and C1977S, which perturb correct folding of Tg protein, caused impaired intracellular transport, leading to accumulation of abnormal Tg in endoplasmic reticulum (9, 15, 16). The mutation C1058R also caused defects in intracellular transport as shown by carbohydrate analysis of Tg protein and increased expression of molecular chaperones in the patients’ thyroid (data not shown). Defective intracellular transport of Tg was also confirmed by the in vitro expression of mutant proteins in heterologous culture cells (data not shown). Allelic frequency of all the mutations was less than 0.01 (data not shown).
The three mutations, C1058R, C1245R, and C1977S, were frequently found in Japan. None of the mutations have been reported in other countries. In the Japanese population as a whole, the overall incidence of Tg mutations is estimated at one in 67,000 live births. This figure is comparable with the one in 66,000 occurrence of total iodide organification defects, the majority of which are caused by mutations in the TPO gene (17). Patients with the mutations C1058R and C1977S were restricted to specific locations within Japan, whereas those with the C1245R mutation were found all over the country. This observation suggests that the C1058R and C1977S mutations originated from a single person (founder effect). In particular, the small village where the C1058R mutation was found is isolated by steep mountains and sea, inhibiting movement to nearby areas. A public health survey in 1964 reported that 55 people of 379 dwellers (14.5%) in the village suffered from goiter (18). When taking into account that only homozygotes present with symptoms, 47% of the dwellers were deemed heterozygous carriers of the mutation.
To evaluate whether these mutations were inherited from a common ancestral chromosome or independently recurrent mutations in heterogeneous genetic backgrounds, we studied 18 SNPs within the coding region of the Tg gene. We (9) and others (13) previously reported 15 SNPs within the Tg gene. In this report, we identified six more SNPs. The frequencies of the minor alleles of these SNPs were relatively rare, i.e. up to 15%. The haplotypes of eight patients with the C1058R mutation and seven patients with the C1977S mutation were identical. When calculated from allelic frequencies of the SNPs in normal controls, the occurrence of the mutations C1058R and C1977S in the Japanese population would be 1.2 x 10–9 and 2.7 x 10–11, respectively. This confirms the hypothesis that homozygous occurrence of C1058R and C1977S was a result of a founder effect. However, three patients with the C1245R mutation possessed different haplotypes from the other nine patients. In particular, some of the SNPs presented with both major and minor alleles in a single patient. These results suggest that the C1245R mutation is an independently recurrent mutation. However, taking into account that nine patients share a common allele, an alternative explanation is that C1245R is an old mutation with the new SNPs being created independently.
In conclusion, we report 26 different mutations of the Tg gene in 52 patients from 41 families. Among three frequently found mutations (C1058R, C1245R, and C1977S), haplotype analysis confirmed that C1245R and C1977S were caused by a founder effect. Therefore, Tg mutations should be considered as one of the genetic causes of familial euthyroid goiter.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
First Published Online May 23, 2006
Abbreviations: SNP, Single-nucleotide polymorphism; Tg, thyroglobulin; TPO, thyroid peroxidase.
Received December 12, 2005.
Accepted May 17, 2006.
|
References |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
A [R2223H]) resulting in fetal goitrous hypothyroidism. J Clin Endocrinol Metab 88:3546–3553C and R277X/R1511X) in the thyroglobulin (TG) gene in affected individuals of a Brazilian kindred with congenital goiter and defective TG synthesis. J Clin Endocrinol Metab 89:646–657This article has been cited by other articles:
 |
|
 |
|
  P. S. Kim, J. Lee, P. Jongsamak, S. Menon, B. Li, S. A. Hossain, J.-H. Bae, B. Panijpan, and P. Arvan Defective Protein Folding and Intracellular Retention of Thyroglobulin-R19K Mutant as a Cause of Human Congenital Goiter Mol. Endocrinol., February 1, 2008; 22(2): 477 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Caputo, C. M Rivolta, V. J Gutnisky, L. Gruneiro-Papendieck, A. Chiesa, G. Medeiros-Neto, R. Gonzalez-Sarmiento, and H. M Targovnik Recurrence of the p.R277X/p.R1511X compound heterozygous mutation in the thyroglobulin gene in unrelated families with congenital goiter and hypothyroidism: haplotype analysis using intragenic thyroglobulin polymorphisms J. Endocrinol., October 1, 2007; 195(1): 167 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kanou, A. Hishinuma, K. Tsunekawa, K. Seki, Y. Mizuno, H. Fujisawa, T. Imai, Y. Miura, T. Nagasaka, C. Yamada, et al. Thyroglobulin Gene Mutations Producing Defective Intracellular Transport of Thyroglobulin Are Associated with Increased Thyroidal Type 2 Iodothyronine Deiodinase Activity J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1451 - 1457. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
